Health & Medical Heart Diseases

Decreasing In-hospital Mortality of Patients Undergoing PCI

Decreasing In-hospital Mortality of Patients Undergoing PCI

Abstract and Introduction

Abstract


Background. Advances in interventional techniques have been dramatic in the last 10 years. The goal of this study was to evaluate the age-adjusted in-hospital mortality rate in patients undergoing percutaneous coronary intervention (PCI) using a large database.
Methods. The Nationwide Inpatient Sample (NIS) database was utilized to calculate the age-adjusted mortality rate for PCI from 1988 to 2004 in patients over the age of 40 retrospectively. Specific ICD-9-CM codes for PCI were used for this study. Demographic data were also analyzed and adjusted for age.
Results. The mean age for these patients was 71.56 ± 10.59 years (53.55% male). From 1988 to 1995, the age-adjusted mortality rate was stable. However, after 1995 the age-adjusted mortality rate showed persistent decline to the lowest level in 2004. (In 1988, age-adjusted mortality rate was 75.43 per 100,000 [95% CI = −7.88–158.76], in 1995, 66.83 per 100,000 [95% CI = 24.62–109.050] and in 2004, 38.38 per 100,000 [95% CI 19.53–57.22]; p < 0.01). Total death also declined from 1.8% to 1.2%. This trend was similar across gender and ethnicities except for Asians. Furthermore, minorities and women had persistently higher mortality in comparison to males and Caucasians.
Conclusion. The age-adjusted in-hospital mortality rate from PCI was steady until 1995 and declined to its lowest level in 2004. Despite this decline, racial and gender disparity in regard to mortality persisted over the study years.

Introduction


Percutaneous coronary intervention (PCI) is the most common interventional procedure for coronary artery revascularization. The number of PCI procedures has increased in recent years due to increased awareness and improved outcomes compared to fibrinolytic therapy for coronary artery disease (CAD). Meta-analyses of randomized clinical trials have reported that primary PCI is more cost-effective compared to fibrinolysis and reduces the incidence of death, reinfarction, and stroke. Furthermore, in stable patients and in patients with multivessel disease, PCI has become the preferred procedure in the United States, with declining mortality in patients undergoing multivessel PCI. Despite increasing utilization of PCI in the United States, the mortality trends from PCI based on race and gender have not been studied in recent years. We sought to identify the temporal trends of in-hospital PCI-related mortality in a large patient cohort from 1998 to 2004 in the United States based on gender and ethnicity.

SHARE
RELATED POSTS on "Health & Medical"
Sparking Innovation: Patients First, Mice Second
Sparking Innovation: Patients First, Mice Second
Beating Heart Disease the Natural Way!
Beating Heart Disease the Natural Way!
Review of Robotic-Assisted, Totally Endoscopic CABG
Review of Robotic-Assisted, Totally Endoscopic CABG
Lower LDL Cholesterol Naturally
Lower LDL Cholesterol Naturally
What is a Good Ratio For LDL to HDL? A Simple Guide
What is a Good Ratio For LDL to HDL? A Simple Guide
Homocysteine Danger Seems to Be Ignored by Doctors
Homocysteine Danger Seems to Be Ignored by Doctors
City Dwellers Have More Heart Disease
City Dwellers Have More Heart Disease
Warning Signs of Heart Disease in Women
Warning Signs of Heart Disease in Women
fish oil infused vegetables
fish oil infused vegetables
Tips For a Healthy Heart
Tips For a Healthy Heart
Understanding Diagnosis and Treatment of Aneurysms
Understanding Diagnosis and Treatment of Aneurysms
Cutting Balloon Angioplasty for Underexpanded Stent
Cutting Balloon Angioplasty for Underexpanded Stent
Five Ways To Lower Cholesterol - And A Case History
Five Ways To Lower Cholesterol - And A Case History
VTE in Primary Care: Patient Management With Rivaroxaban
VTE in Primary Care: Patient Management With Rivaroxaban
What Are the Key Symptoms of Heart Disease?
What Are the Key Symptoms of Heart Disease?
A Few Whiffs of Smoke May Harm Your Heart
A Few Whiffs of Smoke May Harm Your Heart
Giant Cell Myocarditis
Giant Cell Myocarditis
Vitamin C Heart Disease Cure
Vitamin C Heart Disease Cure
Kexin Type 9 Inhibitor Alirocumab in High Risk Patients
Kexin Type 9 Inhibitor Alirocumab in High Risk Patients
Discover How to Lower Cholesterol - Important Techniques For You to Use
Discover How to Lower Cholesterol - Important Techniques For You to Use
Managing Hypertension, Part I: Diuretics
Managing Hypertension, Part I: Diuretics
SAPIEN Transcatheter Heart Valve for High-Risk Aortic Stenosis
SAPIEN Transcatheter Heart Valve for High-Risk Aortic Stenosis

Leave Your Reply

*